Latest Head to Head Trial Results in Hypertension


Science & Innovation Theater Webinar 

Recorded on August 19, 2015 

Presented by Arbor Pharmaceuticals 

Click here to download PDF of presentation


Latest Head to Head Trial Results in Hypertension

Hypertension remains uncontrolled in the US leading to preventable cardiovascular events. There are several options to treat hypertension, but which one is the most efficacious? This presentation will focus on head to head clinical trial results comparing the efficacy and safety between Edarbi, Benicar and Diovan. In addition, combination therapy is often recommended to control hypertension. Head to head studies comparing ARB combinations between Edarbyclor and Benicar HCT will also be reviewed.


Taylor Salinardi, PhD, Medical Science Liaison, Arbor Pharmaceuticals, LLC

Sponsored by:

 Arbor Logo 

This webinar is sponsored, developed and presented by the sponsor.  The content of the Science & Innovation Theater Webinars and opinions expressed by the presenters are those of the sponsor or presenters and not of the Academy of Managed Care Pharmacy.